MedTrace Logo

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

NCT03704545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2025-12-04

No results posted yet for this study

Summary

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return of the patient to his home.

Conditions

Interventions

OTHER

Pharmaceutical consultation at the hospital

During 20 minutes, the patient will be educated about chronic obstructive pulmonary disease treatments and their use.

OTHER

Pharmaceutical consultation at the pharmacy

During 20 minutes, the patient will be educated about chronic obstructive pulmonary disease treatments and their use.

OTHER

Follow-up pharmaceutical consultation at the pharmacy

During 10 minutes, the patient will get more information about his chronic obstructive pulmonary disease treatments and their use.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2021-10-21
Completion
2021-10-21

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03704545 on ClinicalTrials.gov